(5H-chromeno[2,3-b]pyridin-7-yl)-acetonitrile | 52549-06-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: (5H-chromeno[2,3-b]pyridin-7-yl)-acetonitrile
• 英文别名: 7-cyanomethyl-5H-[1]benzopyrano[2,3-b]-pyridine；7-cyanomethyl-5H-[1]benzopyrano[2,3-b]pyridine；2-(5H-chromeno[2,3-b]pyridin-7-yl)acetonitrile
• CAS: 52549-06-1
• 化学式: C₁₄H₁₀N₂O
• 分子量: 222.246
• InChiKey: FWLZADNLKMHMPW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  45.9
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (5H-chromeno[2,3-b]pyridin-7-yl)-acetonitrile 生成 1-(5H-chromeno[2,3-b]pyridin-7-yl)-propan-2-one
  参考文献：
  名称：

  NAKANISI, MITIO;OEH, TAKANORI;TSURUDA, MINEHO

  摘要：

  DOI：
• 作为产物：
  描述：

  (5-oxo-5H-chromeno[2,3-b]pyridin-7-yl)-acetonitrile 以60%的产率得到
  参考文献：
  名称：

  NAKANISHI MICHIO; OE TAKANORI; TSURUDA MINEO; MATSUO HIROSHI; SAKURAGI SH+, YAKUGAKU DZASSI, YAKUGAKU ZASSNI, J. PHARM. SOS. JAR. , 1976, 96+

  摘要：

  DOI：

文献信息

• Substituted alkanoic acids and derivatives
  申请人：Yoshitomi Pharmaceutical Industries, Ltd.

  公开号：US03931205A1

  公开（公告）日：1976-01-06

  Substituted alkanoic acids and derivatives thereof of the formula: ##SPC1## Wherein each of X.sup.1 and X.sup.2 is a hydrogen atom, a halogen atom, an alkyl group having 1 to 4 carbon atoms or an alkoxy group having 1 to 4 carbon atoms; each of R.sup.1 and R.sup.2 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; A is a carbonyl group, a methylene group or an alkylidene group having 2 to 4 carbon atoms; Y is --O--, --S-- or --N(R)-- [wherein R is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms]; Z is OH or Q--B--N(R.sup.3)(R.sup.4) [wherein Q is O (oxygen atom) or NH, B is an alkylene group having 1 to 4 carbon atoms and each of R.sup.3 and R.sup.4 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, or R.sup.3 and R.sup.4 together with the adjacent nitrogen atom form a saturated heterocycle selected from the group consisting of pyrrolidine, piperidine, morpholine, piperazine and piperazine substituted by an alkyl group having 1 to 4 carbon atoms at the 4-position]; and ring P represents a pyridine or a pyridine N-oxide ring; and pharmaceutically acceptable salts thereof are useful as antirheumatics, analgesics, antipyretics and anti-inflammatory agents.

  化学式为：##SPC1## 的取代基脂肪酸及其衍生物，其中X1和X2各自是氢原子，卤素原子，1至4个碳原子的烷基或1至4个碳原子的烷氧基; R1和R2各自是氢原子或1至4个碳原子的烷基; A是羰基基团，亚甲基基团或2至4个碳原子的烷基亚甲基基团; Y是--O--, --S--或--N(R)-- [其中R是氢原子或1至4个碳原子的烷基]; Z是OH或Q--B--N(R3)(R4) [其中Q是O（氧原子）或NH，B是1至4个碳原子的烷基亚基，R3和R4各自是氢原子或1至4个碳原子的烷基，或R3和R4与相邻的氮原子一起形成选自吡咯烷，哌嗪烷，吗啉，哌嗪和在4位处被1至4个碳原子的烷基取代的哌嗪的饱和杂环]; 环P代表吡啶或吡啶N-氧化物环; 以及其药学上可接受的盐可用作抗风湿药，镇痛药，退烧药和抗炎药。
• Tricycle substituted acetones
  申请人：Yoshitomi Pharmaceutical Industries, Ltd.

  公开号：US03974168A1

  公开（公告）日：1976-08-10

  Compounds of the formula: ##SPC1## Wherein Of X.sup.1 and X.sup.2 is a hydrogen atom, a halogen atom or an alkyl group having 1 to 4 carbon atoms; R.sup.1 is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, an alkenyl group having 2 to 4 carbon atoms, an alkynyl group having 2 to 4 carbon atoms or a group -B.sup.1 -R.sup.3 (wherein B.sup.1 is an alkylene group having 1 to 4 carbon atoms, and R.sup.3 is a carboxyl group, an alkoxycarbonyl group in which the alkoxy moiety has 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms or a di-alkyl-amino group in which each alkyl moiety has 1 to 4 carbon atoms); R.sup.2 is an alkyl group having 1 to 4 carbon atoms or a group -B.sup.2 -R.sup.4 (wherein B.sup.2 is an alkylene group having 2 to 4 carbon atoms, and R.sup.4 is a carboxyl group or a di-alkyl-amino group in which each alkyl moiety has 1 to 4 carbon atoms); A is a methylene group or a carbonyl group; Y is an oxygen atom, a sulfur atom or an alkyl-imino group in which the alkyl moiety has 1 to 4 carbon atoms; and Ring P is a pyridine ring; and Pharmaceutically acceptable salts thereof are disclosed. They are useful as anti-inflammatory agents, analgesics, antipyretics and antirheumatics.

  该公式的化合物：##SPC1## 其中X.sup.1和X.sup.2是氢原子、卤素原子或1至4个碳原子的烷基；R.sup.1是氢原子、1至4个碳原子的烷基、2至4个碳原子的烯基、2至4个碳原子的炔基或-B.sup.1-R.sup.3基团（其中B.sup.1是1至4个碳原子的烷基，R.sup.3是羧基、烷氧羰基（其中烷氧基具有1至4个碳原子）、1至4个碳原子的烷氧基或每个烷基均具有1至4个碳原子的二烷基氨基基团）；R.sup.2是1至4个碳原子的烷基或-B.sup.2-R.sup.4基团（其中B.sup.2是2至4个碳原子的烷基，R.sup.4是羧基或每个烷基均具有1至4个碳原子的二烷基氨基基团）；A是亚甲基基或羰基基；Y是氧原子、硫原子或烷基亚氨基基团（其中烷基部分具有1至4个碳原子）；环P是吡啶环；以及其药学上可接受的盐。它们可用作抗炎剂、镇痛剂、退烧剂和抗风湿药物。
• NAKANISI, MITIO;OEH, TAKANORI;TSURUTA, MINEHO
  作者：NAKANISI, MITIO、OEH, TAKANORI、TSURUTA, MINEHO

  DOI：——

  日期：——
• NAKANISI, MITIO;OEH, TAKANORI
  作者：NAKANISI, MITIO、OEH, TAKANORI

  DOI：——

  日期：——
• NAKANISI, MITIO;OEH, TAKANORI;TSURUDA, MINEHO
  作者：NAKANISI, MITIO、OEH, TAKANORI、TSURUDA, MINEHO

  DOI：——

  日期：——